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Available online 1 August 2019Background:Myocardial strain has been shown to predict outcome in various cardiovascular diseases, including
congenital heart diseases. The aim of this study was to evaluate the predictive value of cardiac magnetic reso-
nance (CMR) feature-tracking derived strain parameters in repaired tetralogy of Fallot (rTOF) patients for devel-
oping ventricular tachycardia (VT) and deterioration of ventricular function.
Methods: Patients with rTOF who underwent CMR investigation were included. Strain and strain-rate of both
ventricles were assessed using CMR feature tracking. The primary outcome was a composite of the occurrence
of sustained VT or non-sustained VT requiring invasive therapy. The secondary outcomewas analyzed in patients
that underwent a second CMR after 1.5 to 3.5 years. Deterioration was deﬁned as reduction (≥10%) in right ven-
tricular (RV) ejection fraction, reduction (≥10%) in left ventricular (LV) ejection fraction or increase (≥30mL/m2)
in indexed RV end-diastolic volume compared to baseline.
Results: 172 patients (median age 24.3 years, 54 patients b18 years)were included. Throughout amedian follow-
up of 7.4 years, 9 patients (4.5%) experienced the primary endpoint of VT. Multivariate Cox-regression analysis
showed that LV systolic circumferential strain-rate was independently predictive of primary outcome (p =
0.023). 70 patients underwent a serial CMR, of whom 14 patients (20%) showed ventricular deterioration. Logis-
tic regression showed no predictive value of strain and strain-rate parameters.
Conclusions: In patients with rTOF, LV systolic circumferential strain-rate is an independent predictor for the de-
velopment of VT. Ventricular strain parameters did not predict deterioration of ventricular function in the studied
population.








Tetralogy of Fallot (TOF) is one of the most prevalent types of con-
genital heart diseases, with excellent survival into adulthood when sur-




ability and freedom from bias of
. This is an open access article underprevalence of residual lesions, mostly pulmonary regurgitation (PR),
and late complications, including right ventricular (RV) dysfunction,
often require re-intervention. Previous surgery and progressive RV
and left ventricular (LV) dilatation in combinationwith ventricular dys-
function are believed to form a substrate for electrical instability,
resulting in both atrial- and ventricular tachyarrhythmias and sudden
cardiac death (SCD) [1–3]. Exercise intolerance, signs of heart failure,
QRS prolongation, and RV dilatation form the cornerstone in the risk
stratiﬁcation of patients with repaired TOF (rTOF) [2,4,5]. Cardiac mag-
netic resonance (CMR) imaging is the imaging modality of choice for
measuring ventricular morphology, function, and quantiﬁcation of PR
[6,7]. To identify patients at risk for SCD and aiming at primary preven-
tion, research has focused on identifying parameters predictive of ma-
lignant ventricular arrhythmias [8].the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Baseline characteristics (n= 172).
Male sex 91 (53%)
Age (years) 24.3 (15.9–35.4)
Age at TOF repair (years) 1.6 (1.1–5.2)
Body mass index (kg/m2) 22.4 ± 4.7
Cardiac magnetic resonance
RV EDVi (mL/m2) 125 ± 38
RV ESVi (mL/m2) 62 ± 23
RV mass index (g/m2) 42 ± 11
RV EF (%) 51 ± 8
LV EDVi (mL/m2) 80 ± 17
LV ESVi (mL/m2) 34 ± 11
LV mass index (g/m2) 55 ± 16
LV EF (%) 58 ± 8
PRF (%) 26 ± 17
Echocardiography
PV peak gradient (mmHg) 24 ± 15
Electrocardiography
QRS duration (ms) 136 ± 27
Values are mean± standard deviation or median (interquartile range). BMI body
mass index, LV left ventricular, EDVi indexed end-diastolic volume, ESVi indexed
end-systolic volume, EF ejection fraction, RV right ventricular, PRF pulmonary
regurgitant fraction, PV pulmonary valve.
2 Q.A.J. Hagdorn et al. / International Journal of Cardiology 295 (2019) 1–6Myocardial deformation (strain), measured using cardiac magnetic
resonance feature tracking, has shown to contain additive value in
predicting outcome, when compared to conventional measurements
of ventricular function and volume in various cardiovascular diseases
[9,10]. Even in the absence of impaired ejection fraction (EF), strain var-
iables are affected in heart failure, indicating that strain could be amore
sensitivemarker ofmyocardial dysfunction than EF [11]. Several studies
have shown that in patients with rTOF, both RV and LV deformation,
measured as strain using either echocardiography or CMR, are de-
creased when compared to healthy controls [12–14]. In addition, defor-
mation parameters of both ventricles have been reported to predict
quality of life, exercise capacity and SCD and/or ventricular tachycardia
(VT) in patients with rTOF [15–18]. Furthermore, in patients with rTOF,
RV longitudinal strain, LV circumferential strain, and LV longitudinal
strain were also associated with deterioration of ventricular function
anddilatation over time,when combinedwith conventional parameters
of ventricular function, surgical history and QRS duration [19]. In this
and other studies, deterioration of ventricular function is commonly de-
ﬁned as a composite of either decreased RV EF, decreased LV EF or in-
creased indexed RV end-diastolic volume (EDVi) [19–21].
Ventricular strain is ameasure of relative deformation in a certain di-
rection, with the unit percentage. In contrast, strain-rate measures the
rate of this deformation, and therefore provides conceptually different
information regarding myocardial performance. Furthermore, strain-
rate can be measured during both contraction phase and relaxation
phase, providing information on systolic and diastolic function. The pre-
dictive value of CMR derived strain-rate parameters has not been re-
ported previously in patients with rTOF. Thus, it remains unknown
whether the conceptual differences between strain and strain-rate
translate into different prognostic potential. The aim of this study was
to investigate the value of both CMR-feature tracking derived strain
and strain-rate as predictors for VT, and additionally as a predictor for
deterioration of ventricular function on CMR in patients with rTOF.
2. Methods
Consecutive patients with rTOF, both adults and children, who underwent routine
CMR between January 2007 and March 2016 at the University Medical Center Groningen
were identiﬁed. Patients with pulmonary atresia, absent pulmonary valve, and partial
anomalous pulmonary venous return were excluded. The ﬁrst CMR within the inclusion
period was used for mass and volume, pulmonary artery (PA) ﬂow andmyocardial defor-
mation, as described below. CMR studies with signiﬁcant artifacts limiting study quality
were excluded. Patient characteristics at the time of CMR, including age, sex, and surgical
history were collected from medical records. QRS duration was extracted from the stan-
dard 12 lead electrocardiogram (ECG) obtained b4 months from CMR. Pulmonary valve
(PV) peak gradient was obtained from echocardiography performed within 6 months
from CMR.
Furthermore, a subset of patientswhounderwent a second CMR study, performed be-
tween 1.5 and 3.5 years after the ﬁrst CMR, was identiﬁed. From this second CMR, mass
and volumemeasurements were performed and used to categorize patients into ‘deterio-
ration’ or ‘no deterioration’, as described below. Patients with secondary CMR were ex-
cluded from this analysis if a valvular intervention (i.e. valve replacement,
valvuloplasty)wasperformed between both CMRs. This study conforms to theDeclaration
of Helsinki. The need for individual informed consent for this studywas waived by the in-
stitutional Medical Ethical Review Board.
2.1. CMR imaging protocol
CMR scans were performed using a 1.5 T scanner (Siemens, Erlangen, Germany),
using a retrospectively gated steady-state free- precession (SSFP) sequence, ECG-gated
cine loop images with breath holding at end-expiration were acquired. The four-
chamber and two-chamber views were used for long-axis slices. Short-axis slices were
subsequently acquired covering both ventricles from base to apex. Two-dimensional ve-
locity encoded CMR ﬂow measurements, perpendicular and 1.5 cm cranial to the PV,
were performed using 2-D gradient echo Fast Low Angle SHot (FLASH), acquired during
normal respiration with retrospective cardiac gating.
2.2. CMR analysis
All assessments of mass, volume, function and PA-ﬂowwere performed by two inde-
pendent observers (Q.A.J.H. and T.M.G.), blinded for patient's history. Ventricular mass,
volume, and function were analyzed using QMass 7.6 (Medis Medical Imaging, Leiden,
The Netherlands) according to guidelines of the Society for Cardiovascular MagneticResonance. Good intra- and inter-observer variability analyses in our group have been re-
ported previously [4]. Based on previous experience, the papillary muscle and trabeculae
were excluded from ventricular volumes by using MassK Mode® (semi-automatic
threshold-based segmentation software) [4,22].
PA-ﬂow was analyzed using QFlow 5.6 (Medis Medical Imaging, Leiden, The
Netherlands). PA-contours were semi-automatically generated, and thereafter
manually adjusted. Automated background offset correction was performed,
based on previous experience [7]. Pulmonary regurgitant fraction (PRF) was
calculated.
Strain and strain-rate analyses were performed using QStrain 2.0 (Medis Medical
Imaging, Leiden, The Netherlands) by one observer (J.D.L.V.). In all analyses, strain
was deﬁned as the peak of the global strain curve, systolic strain-rate the peak of
the global strain-rate curve in systole, and diastolic strain-rate the peak in diastole.
RV and LV longitudinal strain analyses were performed in the 4-chamber view, RV
and LV circumferential strain at mid-papillary level using the short-axis view. Endo-
cardial borders were manually traced in end-systole and end-diastole. Feature track-
ing was visually reviewed, and border tracing was manually adjusted if necessary. RV
longitudinal strain was deﬁned as longitudinal strain in the RV free wall. RV delay
was deﬁned as the time difference in time to peak global circumferential strain be-
tween RV and LV. If feature tracking in more than one of the views failed, strain anal-
yses of this patient were not included.
Patient height and weight were extracted from the original CMR report to calculate
body surface area (BSA) using Haycock's formula [23]. All volumes and masses were
indexed for BSA.
2.3. Outcomes
The primary endpoint was a combined endpoint of the occurrence of SCD, sudden
cardiac arrest with successful resuscitation, VT (deﬁned as documented episode of
sustained VT lasting ≥30 s), an appropriate implantable cardioverter deﬁbrillator
(ICD) shock or non-sustained VT (NSVT) requiring invasive therapy (i.e. ICD implan-
tation, VT ablation). Follow-up time was deﬁned as the time from the baseline CMR to
the primary endpoint, or, in the absence of an endpoint, time to the last recorded pa-
tient contact.
The secondary endpoint was deﬁned as deterioration of ventricular function or di-
mensions, based on any of the three criteria: a decrease in RV EF of ≥10% (absolute percent
change), a decrease in LV EF of ≥10% (absolute percent change) or an increase in RV EDVi
of 30 mL/m2, in line with previous studies [19–21].
2.4. Statistics
Statistical analyses were performed using SPSS (version 23, 2015). A p-value below
0.05 was considered statistically signiﬁcant. Data are displayed as mean ± standard devi-
ation (SD) or number (percentage). Continuous variables were compared using indepen-
dent samples t-test and categorical variables using Chi-squared test. Univariate Cox-
regression analysiswas performed to assess thepredictive value of baseline characteristics,
mass and volumemeasures, PRF, and strain for the primary endpoint. Parameters with p b
0.05were included in themultivariate stepwise backward Cox-regression analysis, using p
N 0.1 as criterion for removal. For all parameters with a univariate p b 0.05, a receiver op-
erator characteristic (ROC) curvewas plottedwith the corresponding area under the curve
(AUC) calculations. For the independent parameter in the multivariate analysis, the
Fig. 1. Strain and strain-rate analysis. Representative examples of feature-tracking strain and strain-rate analysis in a patientwithout the primary outcome (no event) and a patient with a
primary outcome (event).
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vival plot was made for the patient group above this cut-off value, compared with the
group below this cut-off value. Associations between CMR parameters and the secondary
outcome of deterioration were assessed using logistic regression. For intra-observer anal-
yses, ten CMR studieswere randomly selected and analyzedby J.D.L.V., at least twomonths
after the original analysis. Even though all deformation analyses in this study were per-
formed by one observer, inter-observer variability was assessed to provide reproducibility
of these measures. Therefore, two blinded observers (J.D.L.V. and S.L.M.) performed defor-
mation analyses in ten randomly selected CMR studies. Two-way mixed intra-class corre-
lation coefﬁcient was used, and mean bias ±SD was calculated. One-sample t-test was
used to assess whether bias was signiﬁcantly different from zero.Table 2
Cox-regression analysis for prediction of VT.
No event Event
mean ± SD mean ± SD
RV longitudinal
Strain (%) −25.1 ± 5.4 −24.3 ± 3.3
Strain-rate systole (1/s) −1.21 ± 0.32 −1.14 ± 0.19
Strain-rate diastole (1/s) 1.21 ± 0.41 1.09 ± 0.52
RV circumferential
Strain (%) −19.9 ± 4.7 −17.2 ± 4.7
Strain-rate systole (1/s) −0.81 ± 0.24 −0.69 ± 0.27
Strain-rate diastole (1/s) 0.88 ± 0.30 0.73 ± 0.40
LV longitudinal
Strain (%) −19.5 ± 4.0 −18.0 ± 5.4
Strain-rate systole (1/s) −1.01 ± 0.28 −0.95 ± 0.33
Strain-rate diastole (1/s) 1.06 ± 0.37 1.02 ± 0.32
LV circumferential
Strain (%) −25.6 ± 5.3 −23.2 ± 4.0
Strain-rate systole (1/s) −1.23 ± 0.25 −0.98 ± 0.28
Strain-rate diastole (1/s) 1.26 ± 0.3 1.01 ± 0.42




Age (years) per Δ10 0.002
RV mass index (g/m2) per Δ5 0.021
QRS duration (ms) per Δ10 0.002
LV circ. strain-rate syst. (1/s) per Δ0.25 0.002
LV circ. strain-rate diast. (1/s) per Δ−0.25 0.021
VT ventricular tachycardia, RV right ventricular, HR hazard ratio, CI conﬁdence interval, LV left3. Results
In total, 172 patients were included in this study, with a median age
at the time of CMR examination of 24.3 years (interquartile range (IQR)
15.9–35.4). Due to signiﬁcant artifacts, 11 patients were excluded. Of
the included patients, 54 patients (31%) were pediatric (b18 years).
Mass and volume measurements could be performed in 169 patients
(98%), pulmonary ﬂow measurements could be performed in 166
patients (97%), and strain measurements could be performed in 166Cox-regression
Step size p-Value HR (95% CI)
per Δ5 0.592 1.19 (0.62–2.29)
per Δ0.25 0.495 1.22 (0.69–2.18)
per Δ−0.25 0.458 1.19 (0.75–1.89)
per Δ5 0.138 1.83 (0.82–4.07)
per Δ0.25 0.158 1.73 (0.81–3.71)
per Δ−0.25 0.185 1.54 (0.81–2.96)
per Δ5 0.436 1.48 (0.55–3.95)
per Δ0.25 0.747 1.11 (0.58–2.11)
per Δ−0.25 0.988 1.00 (0.61–1.66)
per Δ5 0.094 1.35 (0.95–1.93)
per Δ0.25 0.002 3.15 (1.53–6.46)
per Δ−0.25 0.021 2.06 (1.12–3.76)
per Δ25 0.298 1.31 (0.78–2.25)
Multivariate
HR (95% CI) p-Value HR (95% CI)
1.71 (1.12–2.62) 0.090 1.68 (0.92–3.02)
1.38 (1.05–1.73) 0.083 1.36 (0.97–1.83)
1.45 (1.05–2.00) 0.114 1.33 (0.93–1.91)
3.15 (1.53–6.46) 0.023 4.30 (1.22–15.20)
2.06 (1.12–3.76) 0.168 0.47 (0.16–1.37)
ventricular, Circ. Circumferential. Signiﬁcant p-values (b0.05) are bold.
4 Q.A.J. Hagdorn et al. / International Journal of Cardiology 295 (2019) 1–6patients (97%). Within the predeﬁned timeframe, a baseline echocar-
diographic examination was available for 143 patients (83%), and a
baseline ECG examinationwas available for 162 patients (94%). Baseline
characteristics are displayed in Table 1. Intra- and inter-observer vari-
ability analysis showed good reproducibility and precision of strain
and strain-rate measures (Supplementary Table 1).3.1. Primary endpoint: Ventricular tachyarrhythmias
During a median follow-up time of 7.4 years (IQR 4.6–9.4 years), 9 pa-
tients (4.5%) experienced the primary outcome, of whom 6 patients expe-
rienced documented sustained VT, 1 patient experienced an appropriate
ICD shock due to sustained VT in a symptomatic patient, 1 patient
underwent VT ablation for recurrent NSVTs and 1 patient underwent ICD
implantation for recurrent NSVTs. There were no SCDs or cardiac arrest
survivors. Table 2 shows baseline deformation measures for the groups
with orwithout theprimary endpoint, Fig. 1 displays representative exam-
ples of feature tracking analyses from either group. When compared with
normal values, measured using the same software vendor (Medis) in a co-
hort of healthy volunteers, the measured strain and strain-rate values in
the cohort described in this study are all substantially lower [24]. Univari-
ate Cox-regression analysis showed no signiﬁcant associations between
RV-strain variables and primary outcome (Table 2). However, a signiﬁcant
association of both systolic and diastolic LV circumferential strain-rate
with primary outcome was demonstrated. From patient characteristics,
ECG, PV peak gradient, masses, volumes and pulmonary ﬂow, age (p=
0.015), RV mass index (p= 0.022) and QRS duration (p= 0.023) were
identiﬁed as predictors of the primary endpoint of VT (Supplementary
Table 2). A multivariate Cox-regression model, including these variables,
revealed systolic LV circumferential strain-rate as an independent predic-
tor of the primary outcome events (p = 0.023, Table 2). Also when RV
EF and LV EF, which are known predictors in previous studies, were
added to this model or when analyzing RV EF and LV EF, together with
LV systolic and diastolic circumferential strain-rate in a multivariate
model, LV systolic circumferential strain-rate remained signiﬁcantly asso-
ciated with primary outcome (p= 0.007 and p= 0.002, respectively). In
ROC analysis, the predictors which were signiﬁcantly associated with out-
come in univariate analysis showed the followingAUC: LV systolic circum-
ferential strain-rate 0.792 (95% CI 0.605–0.979, p= 0.005), LV diastolic























LV circ. strain-rate systole 0.792
LV circ. strain-rate diastole 0.780
A
Fig. 2. Predictors of VT. a: Receiver-operator characteristic (ROC) curve for prediction of VT. VT v
Meier VT-free survival curve according to LV circumferential systolic strain rate.0.713 (95% CI 0.525–0.901, p = 0.043), RV mass 0.696 (95% CI 0.496–
0.896, p = 0.062) and QRS duration 0.761 (95% CI 0.590–0.933, p =
0.013), displayed in Fig. 2a. The ROC-analysis identiﬁed a systolic LV cir-
cumferential strain-rate of−1.05 as the optimal cut-off value, resulting
in 75% sensitivity and 82% speciﬁcity. As the normal-value for LV circum-
ferential strain-rate is−1.81± 0.43, the cut-off value of−1.05 is substan-
tially lower than normal [24]. Using this cut-off value, a Kaplan-Meier
curve was plotted for VT-free survival of patients with either above or
below the identiﬁed cut-off value of LV circumferential strain-rate
(Fig. 2b). Log Rank analysis showed that using this cut-off point, survival
was signiﬁcantly different between groups (p b 0.001).
3.2. Secondary endpoint: ventricular deterioration
For the secondary outcome of ventricular deterioration, 82 patients
were identiﬁed who had a second CMR examination available within
the predeﬁned timeframe. Of these, 12 underwent pulmonary valve re-
placement (PVR) between both CMRs and were therefore excluded
from this analysis, leaving 70 patients included for secondary endpoint
analysis. Of these, 14 patients were classiﬁed as deteriorated and 56 as
not deteriorated. At baseline, RV EDVi and RV mass index were signiﬁ-
cantly different between the deteriorated and not-deteriorated group
(145.7 ± 29.3 vs. 121.1 ± 32.4 mL/m2, p = 0.012 and 47.0 ± 8.1 vs.
41.5 ± 9.3 g/m2, p = 0.048 respectively). Using logistic regression,
only RV EDVi at baseline appeared signiﬁcantly associatedwith deterio-
ration (p= 0.018, odds ratio 1.26, 95% CI 1.04–1.51 per 10 mL/m2 in-
crease) whereas for RV mass index, there was a borderline signiﬁcant
association (p= 0.055, odds ratio 1.37, 95% CI 1.00–1.88 per 5 g/m2 in-
crease). None of the strain or strain-rate variables were associated with
deterioration (Supplementary Table 3).
4. Discussion
This study describes the value of CMR-feature tracking derived mea-
sures of myocardial deformation for the prediction of VT or deterioration
of ventricular function in patients with rTOF. LV systolic and diastolic cir-
cumferential strain-rate are identiﬁed as strong predictors of VT, ofwhich
LV systolic circumferential strain-rate was an independent predictor. In
contrast, no association could be demonstrated between strain and
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entricular tachycardia, RV right ventricle, LV left ventricle, circ. circumferential. b: Kaplan-
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ROC-analysiswere higher than the previously reported predictorQRSdu-
ration, illustrating the strong predictive value of these parameters.
Two studies that have previously examined the prognostic value of
CMR-feature tracking derived strain parameters for VT and SCD in
rTOF patients. Moon et al. in a case-control cohort including 16 cases
of mainly SCD, showed that both RV and LV longitudinal strain and cir-
cumferential strain were predictors of VT and SCD [16]. Orwat et al. ex-
amined a large, prospective cohort, in which the authors describe a
signiﬁcantly decreased LV circumferential strain and RV longitudinal
strain in the event group when compared with the no-event group
[17]. This is in contrast with the current study, as the studied cohort
did not show decreased strain measures in the VT group when com-
pared with the no event group. Several factors may account for this dif-
ference. At ﬁrst, both previous studies reported a signiﬁcantly lower LV
EF in the SCD/VT groups, whereas in the current cohort, LV EF was not
associated with VT. As strain parameters are known to be correlated
with EF, the preserved LV function might have also resulted in pre-
served strain. The current study shows that even in the absence of im-
paired ventricular function, deformation variables predict clinically
relevant VT, therefore demonstrates the incremental value of deforma-
tion analyses next to conventional CMR variables. Secondly, the cohort
described by Moon et al. experienced mainly SCD as outcome, and the
cohort described by Orwat et al. experienced mainly either NSVT or
SCD, but not sustained VT. In contrast, the latter was the predominant
outcome event in the current study.
Theﬁnding that strain-rate variables are prognosticators of VT, even in
the absence of affected strain parameters, highlights the relevance of
strain-rate parameters in addition to strain. Systolic strain-rate is a con-
ceptually different parameter ofmyocardial contractility than EF or strain,
as it reﬂects the rate atwhich themyocardiumdeforms, rather than abso-
lute proportion of deformation (strain) or volume change (EF). Diastolic
strain-rate could potentially be a new approximation of assessment of di-
astolic function using CMR. The conceptual difference between strain and
strain-rate parameters can explain why in the present study, strain-rate
but not strain parameters proved to be predictive of VT. The message
that the data of the current manuscript contains is therefore twofold. At
ﬁrst, it provides conﬁrmation of results of previous studies, namely that
deformation variables can predict outcome in patients with rTOF. Sec-
ondly, the current manuscript is the ﬁrst to establish that strain-rate can
predict outcome, in a population in which more conventional functional
variables, such as strain and EF, could not. The authors advocate for future
studies to include strain-rate parameters in their analyses.
In contrast to RV deformation variables, LV strain-rate emerged as a
prognosticator of VT in the present cohort. Despite the perception of
many that TOF is a mainly right-sided heart disease, various LV param-
eters have been associatedwith outcome. For example, LV end-diastolic
pressure is prognostic for appropriate ICD discharge, LV dimensions and
function are associated with SCD or VT, and LV strain is associated with
SCD and VT [2,3,16,17,25]. This has also been described in other heart
diseases with altered RV loading conditions, for example pulmonary ar-
terial hypertension (PAH) where LV dimensions correlate with hemo-
dynamics and survival, and LV strain predicts early mortality [26–28].
It thus appears that in right-sided heart diseases, monitoring the LV is
of increasing importance [29]. Mechanical interventricular coupling
could potentially play a role in the affected LV systolic function, as RV di-
latation or RVpressure load leads to decreased LV function [30–32]. Fur-
thermore, in rTOF patients, reduced RV dilatation after valve
replacement resulted in improved LV strain, whereas RV strain was un-
altered [33]. The present study supports the increasing attention for the
LV in right-sided heart diseases.
In the described cohort, deterioration of ventricular functionwas as-
sociatedwith higher RV EDVi and RVmass index at baseline. The higher
RV EDVi in the deterioration group is in accordance with the cohort de-
scribed by Jing et al., but not with the cohort described byWald et al., in
which RV EDVi did not differ between the deteriorated group and notdeteriorated group. Tretter et al. questioned in a recently published ed-
itorialwhether RV volumes should be excluded fromof decisionmaking
in rTOF patients, partly based on data of the INDICATOR cohort, where
no association of pre-operative RV EDVi with all-cause mortality,
aborted SCD or sustained VT after PVR could be demonstrated [34].
However, as the decision for PVR and therefore enrollment in the
study was presumably partly based on RV EDV, this result should be
interpreted with caution. The present study shows that RV EDVi is asso-
ciated with deterioration of ventricular function during follow-upwith-
out valvular interventions or replacements, and remains, therefore, a
useful biomarker for clinical follow-up of rTOF patients.
The present study supports the association between RV mass and
disease progression in rTOF patients. However, none of the studied
CMR-strain variables differed signiﬁcantly between both groups. This
implies no additive value of strain and strain-rate parameters to con-
ventional mass and volume measures for predicting ventricular deteri-
oration. This ﬁnding is in line with the study of Jing et al., although a
later study of this same group suggested an additional prognostic
value of LV circumferential, LV longitudinal and RV longitudinal strain
parameters when combined in a model with conventional CMR mea-
sures using machine learning [19]. In summary, secondary endpoint
analysis shows that increased RVEDVi andmass precede ventricular de-
terioration, but no additional value for strain parameters in the predic-
tion of ventricular deterioration could be demonstrated.
4.1. Study limitations
This retrospective study inevitably comes with limitations. Although
all patients, according to institutional protocol, undergo standardized
follow-up, including CMR examination regularly, patients with contrain-
dications, such as pacemaker implantation, did not undergo CMR, and
were excluded for this studywhichmight have resulted in some selection
bias. The total number of primary endpoint eventswas only nine, limiting
the statistical power ofmultivariate analyses. Also, only a subgroup of pa-
tients that underwent a second CMR examination within the deﬁned
timeframe was included for ventricular deterioration analysis, also hav-
ing the potential for selection bias, and the number of patients in this sub-
group limits the statistical power of deterioration analyses. Whether the
conclusions drawn from these data hold for the general rTOF population
should be addressed by prospective longitudinal studies.
5. Conclusion
The present study shows that systolic LV circumferential strain-rate
is a strongpredictor for theprimary endpoint of VT, independent of con-
ventional variables in a population of both children and adults with
rTOF. Furthermore, RV EDVi was associated with deterioration of ven-
tricular function. On the contrary, no association could be demonstrated
between strain and strain-rate parameters and deterioration of ventric-
ular function. As surveillance for potentially life-threatening arrhyth-
mias and ventricular deterioration is key in the long-term clinical
follow-up of rTOF, the current study suggests that strain-rate parame-
ters may improve risk stratiﬁcation in these patients.
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